Merck
The Pharmaceuticals Industry
Weaknesses
Vision:
- Need more market share
- Potential change in relations with buyer power
- Dividend yield slightly lower than avg : 3.14% vs 3.3%
- Need to diversify
To make a difference in the lives of people globally through our innovative medicines, vaccines, and animal health products. We are committed to being the premier, research-intensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future.
Strengths
Business Strategy
- 1st runner's advantage: Keytruda
- Recent changes in business strategy: Specialized Care
- Good Reputation with investors